Breast cancer is one of the leading causes of death for women worldwide. However, with current treatments there is a 20% chance of local recurrence within ten years, even when cancer is diagnosed in the early stages (Stage I and II). Treatments with a higher efficacy rate are needed to further decrease the likelihood of cancer recurrence. Our specific study used a combination of chemotherapy and immunotherapy: this combination boosts the effectiveness...